‘Clean’ User Fee Bill Becomes More Likely The Longer Talks Drag On

By John Wilkerson / September 16, 2022 at 4:56 PM
The longer talks drag on, the less likely it is that lawmakers attach policy riders to the reauthorization of FDA user fees in stop-gap spending legislation, drug lobbyists said, and lawmakers already missed two self-imposed deadlines for a deal. There’s talk of instead attaching FDA policy riders to omnibus appropriations legislation during the lame-duck session, but lobbyists said that would be difficult to pull off. There are still negotiations over policy riders, but lobbyists said the only ones with much...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.